Skip to search formSkip to main contentSkip to account menu

isoglobotrihexosylceramide

Known as: iGb3 ceramide 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
Isoglobotrihexosylceramide (iGb3) has been identified as a potent CD1d‐presented self‐antigen for mouse invariant natural killer… 
2012
2012
Puga Yung GL, Li Y, Borsig L, Millard A‐L, Karpova MB, Zhou D, Seebach JD. Complete absence of the αGal xenoantigen and… 
2011
2011
Certain glycolipid antigens for natural killer T (NKT) cells can direct the overall cytokine balance of the immune response… 
Highly Cited
2008
Highly Cited
2008
Glycosphingolipids serve as ligands for receptors involved in signal transduction and immune recognition, as exemplified by… 
Highly Cited
2007
Highly Cited
2007
CD1d-restricted natural killer T (NKT) cells, expressing the invariant T cell antigen receptor (TCR) chain encoded by Vα14-Jα18… 
Highly Cited
2007
Highly Cited
2007
Development of invariant natural killer T (iNKT) cells requires the presentation of lipid ligand(s) by CD1d molecules in the… 
2007
2007
Invariant natural killer T (iNKT) cells are innate T lymphocytes that express T cell receptors binding to exogenous and… 
2007
2007
Isoglobotrihexosylceramide (iGb3) is an endogenous antigen of mammalian cells and can stimulate invariant natural killer T (iNKT… 
Highly Cited
2006
Highly Cited
2006
  • C. XiaQ. Yao P. Wang
  • Bioorganic & medicinal chemistry letters
  • 2006
  • Corpus ID: 34409780